Provectis
Mike Teiler is a seasoned pharmaceutical executive with extensive experience in drug development and portfolio management. Currently serving as Chief Pharmaceutical Officer and Pharma Advisor at LeviCure Ltd. since February 2022, Mike also holds the position of Head of Business Development and Licensing at Provectis and is a Principal Consultant at Pharma Portfolio Management Consultants. Previously, Mike co-founded and served as Executive Vice President at Bloomsbury Pharma AI Ltd., and held significant roles at Taro Pharmaceutical Industries and Teva Pharmaceuticals, where key achievements included creating efficient communication networks and managing large-scale global projects with substantial budgets. Mike holds a Bachelor of Pharmacy from The Hebrew University of Jerusalem and is engaged in advanced business studies at Tel Aviv University.
This person is not in any teams
This person is not in any offices
Provectis
Provectis Healthcare AG is a global healthcare company headquarted in Basel, Switzerland to be the commercial partner of choice to the innovative pharma and biotech companies. We in-license innovative medicines and launch in Europe, Asia and Middle East. The experienced Provectis team, with their complementary expertise in clinical development, regulatory, access, medical and commercial excellence, would be an ideal choice for emerging Biopharma companies to realize successful launches and effective product life cycle management